Benchling is a cloud-based software platform for biology researchers and R&D organizations. It makes life science research faster and more collaborative.
Biotechnology has the potential to solve humanity’s most pressing challenges, such as disease, renewable energy, clean water, and hunger.
Benchling was founded in 2012 by Sajith Wickramasekara, Ashu Singhal and Cory Li. The company is headquartered in San Francisco, California.
Benchling offers a modern approach to note-taking. Its collaboration features; integration with Benchling's Bioregistry and Sample Tracking, Molecular Biology Suite, and Workflow Tools; rich search functions; and intuitive user interface encourage usage, so scientists can focus on the science.
Benchling's R&D Cloud is used by over 600 companies, including some of the world's most innovative biotech companies, including 22 of the 50 largest global biopharma companies.
Benchling's free community edition for academics has grown to over 200,000 scientists at more than 7,000 academic and research institutions.
Benchling is backed by Sequoia, Alkeon Capital, Thrive Capital, Franklin Templeton, Altimeter, ICONIQ, Lux Capital, Spark Capital, Tiger Global, Lone Pine Capital, Benchmark, Menlo Ventures, and others. The company raised $100M in Series F round on Nov 18, 2021. This brings Benchling's total funding to $411.9M to date. The latest round pushed the company's valuation to $6.1B, from a $4B landed after their Series E raised in Apr 2021.